NAT10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.035600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.157600E-01
Normal-vs-Stage2
9.199400E-01
Normal-vs-Stage3
2.740200E-01
Normal-vs-Stage4
9.081200E-01
Stage1-vs-Stage2
7.375600E-01
Stage1-vs-Stage3
1.973570E-01
Stage1-vs-Stage4
6.432200E-01
Stage2-vs-Stage3
4.163700E-02
Stage2-vs-Stage4
7.410600E-01
Stage3-vs-Stage4
1.169040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.231400E-01
Normal-vs-AfricanAmerican
6.439600E-01
Normal-vs-Asian
7.164000E-01
Caucasian-vs-AfricanAmerican
6.330200E-01
Caucasian-vs-Asian
8.056800E-01
AfricanAmerican-vs-Asian
7.418800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.448000E-01
Normal-vs-Female
6.497400E-01
Male-vs-Female
1.334600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.114400E-01
Normal-vs-Age(41-60Yrs)
9.978800E-01
Normal-vs-Age(61-80Yrs)
7.069000E-01
Normal-vs-Age(81-100Yrs)
9.885400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.757800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.172000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.695600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.556950E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.724600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.048200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.444000E-01
Normal-vs-Daily Drinker
9.397800E-01
Normal-vs-Weekly Drinker
7.404800E-01
Normal-vs-Occasional Drinker
8.402400E-01
Normal-vs-Social Drinker
9.971600E-01
Non Drinker-vs-Daily Drinker
4.385600E-01
Non Drinker-vs-Weekly Drinker
7.647000E-01
Non Drinker-vs-Occasional Drinker
1.627230E-01
Non Drinker-vs-Social Drinker
3.563200E-01
Daily Drinker-vs-Weekly Drinker
6.921600E-01
Daily Drinker-vs-Occasional Drinker
5.992000E-01
Daily Drinker-vs-Social Drinker
8.830400E-01
Weekly Drinker-vs-Occasional Drinker
3.164200E-01
Weekly Drinker-vs-Social Drinker
5.540600E-01
Occasional Drinker-vs-Social Drinker
6.979800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.197400E-01
Normal-vs-Grade 2
8.258400E-02
Normal-vs-Grade 3
6.655600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.179510E-02
Grade 1-vs-Grade 3
2.464400E-03
Grade 1-vs-Grade 4
4.197400E-01
Grade 2-vs-Grade 3
1.516390E-01
Grade 2-vs-Grade 4
8.258400E-02
Grade 3-vs-Grade 4
6.655600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.824400E-01
Normal-vs-NonDiabetic
7.433400E-01
Diabetic-vs-NonDiabetic
9.665000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.975200E-01
Normal-vs-NoPancreatitis
6.857400E-01
Pancreatitis-vs-NoPancreatitis
1.554360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.950200E-01
Normal-vs-N1
8.554600E-01
N0-vs-N1
7.398400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.324000E-01
Normal-vs-TP53-NonMutant
8.191000E-01
TP53-Mutant-vs-TP53-NonMutant
6.579200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
